---
title: "Pathology Managed Service for Midlands & East 2 Network"
ocid: "ocds-h6vhtk-06c336"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06c336"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-06c336.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-06c336.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST"
published: "2026-07-03"
---

# Pathology Managed Service for Midlands & East 2 Network

Buyer: KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST  
Current stage: Award  
OCID: ocds-h6vhtk-06c336

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06c336)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-06c336.json)

## Summary

The Midlands and East 2 Network, comprising several NHS Trusts including Kettering General Hospital NHS Foundation Trust, has completed the award stage of a procurement process for a pathology managed service. This service is under the NHS Supply Chain Framework for Laboratory Diagnostics and Pathology Managed Services, with the contract awarded to Roche Diagnostics Ltd. The procurement falls within the industry category of pathology services, with the procurement method classified as a limited award procedure, not involving prior publication of a notice. The contract, valued at approximately £13 million for Phase 1 services, was signed on 4th June 2026 and encompasses various locations across the Midlands, including Derby, Burton, and Chesterfield, as part of the comprehensive NHS collaboration framework.

This contract presents significant growth opportunities for businesses operating within the healthcare services industry, especially those specialising in laboratory diagnostics and managed healthcare services. The contract involves substantial responsibilities, including managing a wide range of pathology services from biochemistry to microbiology, making it suitable for large enterprises with robust capabilities in healthcare service delivery. Potential subcontractors may also find opportunities in the provision of phase 2 services, as Roche Diagnostics Ltd. will collaborate with the NHS network to identify and award subcontracts, ensuring value for money and high-quality service delivery. This presents a valuable entry point for companies looking to engage in the public health sector, particularly those offering specialist biochemistry and haematology services.

## Notice

The Midlands and East 2 Network (the "ME2 Network") is a network-wide pathology collaboration in the Midlands and East 2 region, comprising the Contracting Authorities listed in this notice. The ME2 Network carried out a further competition for a pathology managed service under the NHS Supply Chain Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service Framework in accordance with the Public Contracts Regulations 2015. This contract award notice covers the contract for a pathology managed service awarded by the contracting authority in section I.1 of this notice

### Lot Information

Lot 1

The Midlands East 2 Pathology Network is made of the following NHS Trusts: University Hospitals of Derby and Burton NHS Foundation Trust; Chesterfield Royal Hospital NHS Foundation Trust; Kettering General Hospital NHS Foundation Trust; Northampton General Hospital NHS Trust; University Hospitals of Leicester NHS Trust; Nottingham University Hospitals NHS Trust; Sherwood Forest Hospitals NHS Foundation Trust; United Lincolnshire Hospitals NHS Trust; and Northern Lincolnshire and Goole NHS Foundation Trust ("ME2 Network"). The ME2 Network carried out a further competition under Lot 1 of the NHS Supply Chain Framework Agreement for Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services (Framework reference number 2023 S/00 028831) to select a pathology managed service provider (the "Successful Supplier"). Kettering General Hospital NHS Foundation Trust has entered into its own contract with the Successful Supplier. This contract award notice is being published by Kettering General Hospital NHS Foundation Trust. The other NHS Trusts listed as part of the ME2 Network have also entered into separate contracts with the Successful Supplier although note that Northern Lincolnshire and Goole NHS Foundation Trust will enter into its contract for and on behalf of itself and United Lincolnshire Hospitals NHS Trust as the "Path Links" arrangement and this also includes pathology provision at Grimsby, Scunthorpe, Lincoln, Boston and Grantham hospitals and "Derbyshire Pathology" is hosted by University Hospitals of Derby and Burton NHS Foundation Trust, which includes Derby, Burton and Chesterfield Pathology services. The contract includes Phase 1 services: general managed services, biochemistry (including some elements of immunology and serology) and haematology services (including coagulation), pre and post analytical equipment with associated IT and middleware; and Phase 2 services: immunology, blood transfusion, POCT, specialist biochemistry, specialist haematology, cellular pathology (histopathology and mortuary), microbiology (molecular microbiology, bacteriology, serology (including virology)). In accordance with the terms of the contract, the Successful Supplier is responsible for the provision of Phase 1 services in accordance with the implementation plans set out in the contract. The initial ten (10) year term will begin from the ME2 Network Actual Services Commencement Date (the date that the first of the ME2 Network contracts actually commences the delivery of all Phase 1 Services). The term of the contract may be extended for up to 2 years. The Successful Supplier is required to work in collaboration with the ME2 Network to fully develop each of the NHS Trusts' requirements for phase 2 sub-disciplines, test the market and award the winning supplier (a sub-contractor) to provide the relevant Phase 2 service discipline, to ensure value for money and quality of delivery. The Successful Supplier will be responsible for fully managing its sub-contractors under the terms of the contract. The contract sets out the process and governance arrangements for initiating and delivering phase 2 services. The contract value of the Phase 1 services is approximately PS13 million. It is anticipated that the contract value of both Phase 1 and Phase 2 services shall be somewhere between PS13 million and PS45 million Additional information: The value of the contract referred to in section II.I.7 refers to the contract value of the Phase 1 services which is approximately PS13 million. It is anticipated that the contract value of both Phase 1 and Phase 2 services shall be somewhere between PS13 million and PS45 million

Options: The initial ten (10) year term will begin from the ME2 Network Actual Services Commencement Date (the date that the first of the ME2 Network contracts actually commences the delivery of all Phase 1 Services). The term of the contract may be extended for up to 2 years.

### Procurement Information

The contract was awarded following a further competition under Lot 1 of the NHS Supply Chain Framework Agreement for Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services (Framework reference number 2023 S/00 028831) in accordance with the Public Contracts Regulations 2015 ("PCR"). There was therefore no prior publication of a notice and this contract award notice is being published for transparency as there is no obligation to publish a contract award notice following a further competition under a Framework Agreement under the PCR.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/062698-2026 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 3 Jul 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 3 Jun 2026 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £13,000,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST |
| Locality | KETTERING |
| Post town | Northampton |
| Postcode | NN16 8UZ |
| Country | England |
| ITL 1 | TLF East Midlands (England) |
| ITL 2 | TLF2 Leicestershire, Rutland and Northamptonshire |
| ITL 3 | TLF25 North Northamptonshire |
| Local authority | North Northamptonshire |
| Electoral ward | Northall |
| Westminster constituency | Kettering |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ROCHE DIAGNOSTICS |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85111800 - Pathology services

## Release History

- 3 Jul 2026 at 10:37 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/062698-2026

## Notice URLs

- https://www.kgh.nhs.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06c336. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-06c336.json.